Product Information
COSOPT EYE DROPS is a brand product labeled by Thea Pharma Inc., priced at $23.1615 per ML under NDC 82584060510. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Apr 7, 1998. Its Orange Book therapeutic-equivalence code is AT1.
The High Outlier badge above means this manufacturer's average price in the dorzolamide hydrochloride and timolol maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20; 5 mg/mL; mg/mL
Manufacturer
Thea Pharma Inc.NDC
82584060510
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATEApproval Type
New Drug (NDA)
FDA Application
NDA020869FDA Approved
4/7/1998
TE Code
AT1
On Market Since
11/10/2022
Pharmacological Classes
Price Statistics
The NADAC for COSOPT EYE DROPS has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 7.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.1615 per ML |
|---|---|
| All-time high | $23.3360 (Mar 12, 2025) |
| All-time low | $21.5646 (Apr 17, 2024) |
| 52-week high | $23.2620 |
| 52-week low | $23.1437 |
| Median price | $23.2230 |
| Average price | $23.1941 |
| Largest weekly change | +8.0% (May 8, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dorzolamide hydrochloride and timolol maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Thea Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dorzolamide hydrochloride and timolol maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carbonic Anhydrase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COSOPT EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for COSOPT EYE DROPS, manufactured by Thea Pharma Inc., is $23.1615 per ML (NDC 82584060510), effective Sep 30, 2026.
How has the price of COSOPT EYE DROPS changed over time?
Over the history we have for it, the NADAC for COSOPT EYE DROPS has risen 7.4%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for COSOPT EYE DROPS?
Since Apr 17, 2024, the NADAC for COSOPT EYE DROPS has ranged from a low of $21.5646 (Apr 17, 2024) to a high of $23.3360 (Mar 12, 2025), with a median of $23.2230 per ML.
Are there cheaper alternatives to COSOPT EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of COSOPT EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COSOPT EYE DROPS?
COSOPT EYE DROPS (NDC 82584060510) is labeled by Thea Pharma Inc., and CMS classifies it as a brand product.